Global Hip Tendinitis Market Growth (Status and Outlook) 2026-2032

August 2026 | 120 pages | ID: GF939CC9DFA8EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Hip Tendinitis market size is predicted to grow from US$ 323 million in 2025 to US$ 457 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Hip tendinitis is an uncomfortable inflammatory condition when a tendon in the hip becomes iritated or inflamed. Other names for it include hip tendonitis and hip flexor tendonitis. The rapidly increasing rate of the senior population worldwide and growing sports activities are primarily increasing the demand for hip tendonitis treatment.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Hip Tendinitis Industry Forecast” looks at past sales and reviews total world Hip Tendinitis sales in 2025, providing a comprehensive analysis by region and market sector of projected Hip Tendinitis sales for 2026 through 2032. With Hip Tendinitis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hip Tendinitis industry.

This Insight Report provides a comprehensive analysis of the global Hip Tendinitis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hip Tendinitis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hip Tendinitis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hip Tendinitis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hip Tendinitis.

This report presents a comprehensive overview, market shares, and growth opportunities of Hip Tendinitis market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Internal Snapping Hip
  • External Snapping Hip
  • Intra-articular Snapping Hip
Segmentation by Application:
  • Hospitals & Clinics
  • Medical Research Centers
  • Academic Institutes
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Almatica Pharma
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim Pharmaceuticals
  • Merck & Co.
  • Pfizer
  • Abbott
  • GlaxoSmithKline
  • Teva Pharmaceuticals
  • Lupin Pharmaceuticals
  • Geri-Care Pharmaceuticals
  • Perrigo Company
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
    2.1.1 Global Hip Tendinitis Market Size (2021-2032)
    2.1.2 Hip Tendinitis Market Size CAGR by Region (2021 VS 2025 VS 2032)
    2.1.3 World Current & Future Analysis for Hip Tendinitis by Country/Region (2021, 2025 & 2032)
  2.2 Hip Tendinitis Segment by Type
    2.2.1 Internal Snapping Hip
    2.2.2 External Snapping Hip
    2.2.3 Intra-articular Snapping Hip
    2.2.4 Hip Tendinitis Market Size by Type
      2.2.4.1 Hip Tendinitis Market Size CAGR by Type (2021 VS 2025 VS 2032)
      2.2.4.2 Global Hip Tendinitis Market Size Market Share by Type (2021-2026)
  2.3 Hip Tendinitis Segment by Application
    2.3.1 Hospitals & Clinics
    2.3.2 Medical Research Centers
    2.3.3 Academic Institutes
    2.3.4 Others
    2.3.5 Hip Tendinitis Market Size by Application
      2.3.5.1 Hip Tendinitis Market Size CAGR by Application (2021 VS 2025 VS 2032)
      2.3.5.2 Global Hip Tendinitis Market Size Market Share by Application (2021-2026)

3 HIP TENDINITIS MARKET SIZE BY PLAYER

  3.1 Hip Tendinitis Market Size Market Share by Player
    3.1.1 Global Hip Tendinitis Revenue by Player (2021-2026)
    3.1.2 Global Hip Tendinitis Revenue Market Share by Player (2021-2026)
  3.2 Global Hip Tendinitis Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
    3.3.1 Competition Landscape Analysis
    3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 HIP TENDINITIS BY REGION

  4.1 Hip Tendinitis Market Size by Region (2021-2026)
  4.2 Global Hip Tendinitis Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Hip Tendinitis Market Size Growth (2021-2026)
  4.4 APAC Hip Tendinitis Market Size Growth (2021-2026)
  4.5 Europe Hip Tendinitis Market Size Growth (2021-2026)
  4.6 Middle East & Africa Hip Tendinitis Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Hip Tendinitis Market Size by Country (2021-2026)
  5.2 Americas Hip Tendinitis Market Size by Type (2021-2026)
  5.3 Americas Hip Tendinitis Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Hip Tendinitis Market Size by Region (2021-2026)
  6.2 APAC Hip Tendinitis Market Size by Type (2021-2026)
  6.3 APAC Hip Tendinitis Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Hip Tendinitis Market Size by Country (2021-2026)
  7.2 Europe Hip Tendinitis Market Size by Type (2021-2026)
  7.3 Europe Hip Tendinitis Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Hip Tendinitis by Region (2021-2026)
  8.2 Middle East & Africa Hip Tendinitis Market Size by Type (2021-2026)
  8.3 Middle East & Africa Hip Tendinitis Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL HIP TENDINITIS MARKET FORECAST

  10.1 Global Hip Tendinitis Forecast by Region (2027-2032)
    10.1.1 Global Hip Tendinitis Forecast by Region (2027-2032)
    10.1.2 Americas Hip Tendinitis Forecast
    10.1.3 APAC Hip Tendinitis Forecast
    10.1.4 Europe Hip Tendinitis Forecast
    10.1.5 Middle East & Africa Hip Tendinitis Forecast
  10.2 Americas Hip Tendinitis Forecast by Country (2027-2032)
    10.2.1 United States Market Hip Tendinitis Forecast
    10.2.2 Canada Market Hip Tendinitis Forecast
    10.2.3 Mexico Market Hip Tendinitis Forecast
    10.2.4 Brazil Market Hip Tendinitis Forecast
  10.3 APAC Hip Tendinitis Forecast by Region (2027-2032)
    10.3.1 China Hip Tendinitis Market Forecast
    10.3.2 Japan Market Hip Tendinitis Forecast
    10.3.3 Korea Market Hip Tendinitis Forecast
    10.3.4 Southeast Asia Market Hip Tendinitis Forecast
    10.3.5 India Market Hip Tendinitis Forecast
    10.3.6 Australia Market Hip Tendinitis Forecast
  10.4 Europe Hip Tendinitis Forecast by Country (2027-2032)
    10.4.1 Germany Market Hip Tendinitis Forecast
    10.4.2 France Market Hip Tendinitis Forecast
    10.4.3 UK Market Hip Tendinitis Forecast
    10.4.4 Italy Market Hip Tendinitis Forecast
    10.4.5 Russia Market Hip Tendinitis Forecast
  10.5 Middle East & Africa Hip Tendinitis Forecast by Region (2027-2032)
    10.5.1 Egypt Market Hip Tendinitis Forecast
    10.5.2 South Africa Market Hip Tendinitis Forecast
    10.5.3 Israel Market Hip Tendinitis Forecast
    10.5.4 Turkey Market Hip Tendinitis Forecast
  10.6 Global Hip Tendinitis Forecast by Type (2027-2032)
  10.7 Global Hip Tendinitis Forecast by Application (2027-2032)
    10.7.1 GCC Countries Market Hip Tendinitis Forecast

11 KEY PLAYERS ANALYSIS

  11.1 Almatica Pharma
    11.1.1 Almatica Pharma Company Information
    11.1.2 Almatica Pharma Hip Tendinitis Product Offered
    11.1.3 Almatica Pharma Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.1.4 Almatica Pharma Main Business Overview
    11.1.5 Almatica Pharma Latest Developments
  11.2 AstraZeneca
    11.2.1 AstraZeneca Company Information
    11.2.2 AstraZeneca Hip Tendinitis Product Offered
    11.2.3 AstraZeneca Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.2.4 AstraZeneca Main Business Overview
    11.2.5 AstraZeneca Latest Developments
  11.3 Bayer
    11.3.1 Bayer Company Information
    11.3.2 Bayer Hip Tendinitis Product Offered
    11.3.3 Bayer Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.3.4 Bayer Main Business Overview
    11.3.5 Bayer Latest Developments
  11.4 Boehringer Ingelheim Pharmaceuticals
    11.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
    11.4.2 Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Product Offered
    11.4.3 Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.4.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
    11.4.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
  11.5 Merck & Co.
    11.5.1 Merck & Co. Company Information
    11.5.2 Merck & Co. Hip Tendinitis Product Offered
    11.5.3 Merck & Co. Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.5.4 Merck & Co. Main Business Overview
    11.5.5 Merck & Co. Latest Developments
  11.6 Pfizer
    11.6.1 Pfizer Company Information
    11.6.2 Pfizer Hip Tendinitis Product Offered
    11.6.3 Pfizer Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.6.4 Pfizer Main Business Overview
    11.6.5 Pfizer Latest Developments
  11.7 Abbott
    11.7.1 Abbott Company Information
    11.7.2 Abbott Hip Tendinitis Product Offered
    11.7.3 Abbott Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.7.4 Abbott Main Business Overview
    11.7.5 Abbott Latest Developments
  11.8 GlaxoSmithKline
    11.8.1 GlaxoSmithKline Company Information
    11.8.2 GlaxoSmithKline Hip Tendinitis Product Offered
    11.8.3 GlaxoSmithKline Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.8.4 GlaxoSmithKline Main Business Overview
    11.8.5 GlaxoSmithKline Latest Developments
  11.9 Teva Pharmaceuticals
    11.9.1 Teva Pharmaceuticals Company Information
    11.9.2 Teva Pharmaceuticals Hip Tendinitis Product Offered
    11.9.3 Teva Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.9.4 Teva Pharmaceuticals Main Business Overview
    11.9.5 Teva Pharmaceuticals Latest Developments
  11.10 Lupin Pharmaceuticals
    11.10.1 Lupin Pharmaceuticals Company Information
    11.10.2 Lupin Pharmaceuticals Hip Tendinitis Product Offered
    11.10.3 Lupin Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.10.4 Lupin Pharmaceuticals Main Business Overview
    11.10.5 Lupin Pharmaceuticals Latest Developments
  11.11 Geri-Care Pharmaceuticals
    11.11.1 Geri-Care Pharmaceuticals Company Information
    11.11.2 Geri-Care Pharmaceuticals Hip Tendinitis Product Offered
    11.11.3 Geri-Care Pharmaceuticals Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.11.4 Geri-Care Pharmaceuticals Main Business Overview
    11.11.5 Geri-Care Pharmaceuticals Latest Developments
  11.12 Perrigo Company
    11.12.1 Perrigo Company Company Information
    11.12.2 Perrigo Company Hip Tendinitis Product Offered
    11.12.3 Perrigo Company Hip Tendinitis Revenue, Gross Margin and Market Share (2021-2026)
    11.12.4 Perrigo Company Main Business Overview
    11.12.5 Perrigo Company Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Hip Tendinitis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hip Tendinitis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Internal Snapping Hip
Table 4. Major Players of External Snapping Hip
Table 5. Major Players of Intra-articular Snapping Hip
Table 6. Hip Tendinitis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Hip Tendinitis Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Hip Tendinitis Market Size Market Share by Type (2021-2026)
Table 9. Hip Tendinitis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Hip Tendinitis Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Hip Tendinitis Market Size Market Share by Application (2021-2026)
Table 12. Global Hip Tendinitis Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Hip Tendinitis Revenue Market Share by Player (2021-2026)
Table 14. Hip Tendinitis Key Players Head office and Products Offered
Table 15. Hip Tendinitis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Hip Tendinitis Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Hip Tendinitis Market Size Market Share by Region (2021-2026)
Table 20. Global Hip Tendinitis Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Hip Tendinitis Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Hip Tendinitis Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Hip Tendinitis Market Size Market Share by Country (2021-2026)
Table 24. Americas Hip Tendinitis Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Hip Tendinitis Market Size Market Share by Type (2021-2026)
Table 26. Americas Hip Tendinitis Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Hip Tendinitis Market Size Market Share by Application (2021-2026)
Table 28. APAC Hip Tendinitis Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Hip Tendinitis Market Size Market Share by Region (2021-2026)
Table 30. APAC Hip Tendinitis Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Hip Tendinitis Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Hip Tendinitis Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Hip Tendinitis Market Size Market Share by Country (2021-2026)
Table 34. Europe Hip Tendinitis Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Hip Tendinitis Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Hip Tendinitis Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Hip Tendinitis Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Hip Tendinitis Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Hip Tendinitis
Table 40. Key Market Challenges & Risks of Hip Tendinitis
Table 41. Key Industry Trends of Hip Tendinitis
Table 42. Global Hip Tendinitis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Hip Tendinitis Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Hip Tendinitis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Hip Tendinitis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Almatica Pharma Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 47. Almatica Pharma Hip Tendinitis Product Offered
Table 48. Almatica Pharma Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Almatica Pharma Main Business
Table 50. Almatica Pharma Latest Developments
Table 51. AstraZeneca Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 52. AstraZeneca Hip Tendinitis Product Offered
Table 53. AstraZeneca Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. AstraZeneca Main Business
Table 55. AstraZeneca Latest Developments
Table 56. Bayer Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 57. Bayer Hip Tendinitis Product Offered
Table 58. Bayer Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Bayer Main Business
Table 60. Bayer Latest Developments
Table 61. Boehringer Ingelheim Pharmaceuticals Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 62. Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Product Offered
Table 63. Boehringer Ingelheim Pharmaceuticals Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Boehringer Ingelheim Pharmaceuticals Main Business
Table 65. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 66. Merck & Co. Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 67. Merck & Co. Hip Tendinitis Product Offered
Table 68. Merck & Co. Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Merck & Co. Main Business
Table 70. Merck & Co. Latest Developments
Table 71. Pfizer Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 72. Pfizer Hip Tendinitis Product Offered
Table 73. Pfizer Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Pfizer Main Business
Table 75. Pfizer Latest Developments
Table 76. Abbott Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 77. Abbott Hip Tendinitis Product Offered
Table 78. Abbott Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Abbott Main Business
Table 80. Abbott Latest Developments
Table 81. GlaxoSmithKline Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 82. GlaxoSmithKline Hip Tendinitis Product Offered
Table 83. GlaxoSmithKline Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. GlaxoSmithKline Main Business
Table 85. GlaxoSmithKline Latest Developments
Table 86. Teva Pharmaceuticals Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 87. Teva Pharmaceuticals Hip Tendinitis Product Offered
Table 88. Teva Pharmaceuticals Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Teva Pharmaceuticals Main Business
Table 90. Teva Pharmaceuticals Latest Developments
Table 91. Lupin Pharmaceuticals Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 92. Lupin Pharmaceuticals Hip Tendinitis Product Offered
Table 93. Lupin Pharmaceuticals Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Lupin Pharmaceuticals Main Business
Table 95. Lupin Pharmaceuticals Latest Developments
Table 96. Geri-Care Pharmaceuticals Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 97. Geri-Care Pharmaceuticals Hip Tendinitis Product Offered
Table 98. Geri-Care Pharmaceuticals Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Geri-Care Pharmaceuticals Main Business
Table 100. Geri-Care Pharmaceuticals Latest Developments
Table 101. Perrigo Company Details, Company Type, Hip Tendinitis Area Served and Its Competitors
Table 102. Perrigo Company Hip Tendinitis Product Offered
Table 103. Perrigo Company Hip Tendinitis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Perrigo Company Main Business
Table 105. Perrigo Company Latest Developments

LIST OF FIGURES

Figure 1. Hip Tendinitis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hip Tendinitis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hip Tendinitis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hip Tendinitis Sales Market Share by Country/Region (2025)
Figure 8. Hip Tendinitis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hip Tendinitis Market Size Market Share by Type in 2025
Figure 10. Hip Tendinitis in Hospitals & Clinics
Figure 11. Global Hip Tendinitis Market: Hospitals & Clinics (2021-2026) & ($ millions)
Figure 12. Hip Tendinitis in Medical Research Centers
Figure 13. Global Hip Tendinitis Market: Medical Research Centers (2021-2026) & ($ millions)
Figure 14. Hip Tendinitis in Academic Institutes
Figure 15. Global Hip Tendinitis Market: Academic Institutes (2021-2026) & ($ millions)
Figure 16. Hip Tendinitis in Others
Figure 17. Global Hip Tendinitis Market: Others (2021-2026) & ($ millions)
Figure 18. Global Hip Tendinitis Market Size Market Share by Application in 2025
Figure 19. Global Hip Tendinitis Revenue Market Share by Player in 2025
Figure 20. Global Hip Tendinitis Market Size Market Share by Region (2021-2026)
Figure 21. Americas Hip Tendinitis Market Size 2021-2026 ($ millions)
Figure 22. APAC Hip Tendinitis Market Size 2021-2026 ($ millions)
Figure 23. Europe Hip Tendinitis Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Hip Tendinitis Market Size 2021-2026 ($ millions)
Figure 25. Americas Hip Tendinitis Value Market Share by Country in 2025
Figure 26. United States Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Hip Tendinitis Market Size Market Share by Region in 2025
Figure 31. APAC Hip Tendinitis Market Size Market Share by Type (2021-2026)
Figure 32. APAC Hip Tendinitis Market Size Market Share by Application (2021-2026)
Figure 33. China Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 37. India Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Hip Tendinitis Market Size Market Share by Country in 2025
Figure 40. Europe Hip Tendinitis Market Size Market Share by Type (2021-2026)
Figure 41. Europe Hip Tendinitis Market Size Market Share by Application (2021-2026)
Figure 42. Germany Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 43. France Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Hip Tendinitis Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Hip Tendinitis Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Hip Tendinitis Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Hip Tendinitis Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 56. APAC Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 57. Europe Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 59. United States Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 60. Canada Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 61. Mexico Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 62. Brazil Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 63. China Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 64. Japan Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 65. Korea Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 67. India Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 68. Australia Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 69. Germany Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 70. France Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 71. UK Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 72. Italy Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 73. Russia Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 74. Egypt Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 75. South Africa Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 76. Israel Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 77. Turkey Hip Tendinitis Market Size 2027-2032 ($ millions)
Figure 78. Global Hip Tendinitis Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Hip Tendinitis Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Hip Tendinitis Market Size 2027-2032 ($ millions)


More Publications